Outcome
    Moderate Evidence
    Effectiveness 4/5

    Myo-Inositol for Menstrual Cycle Regulation

    Most women with insulin-resistant PCOS see cycles normalise within 3-6 months on 4 g daily.

    Overview

    Myo-inositol restores more regular cycles in a meaningful proportion of women with polycystic ovary syndrome, which is the population where nearly all the evidence sits. Meta-analytic data show improved ovulation rates and better insulin sensitivity markers over three to six months. Outside PCOS, evidence for cycle regulation is sparse. Irregular cycles have many causes, and thyroid disease, hyperprolactinaemia and hypothalamic amenorrhoea will not respond to inositol.
    Compared with metformin, inositol produces broadly similar metabolic and ovulatory improvements in several trials with markedly fewer gastrointestinal side effects, which is the main reason it has become a common first step. The verdict sits at likely because trials are mostly small, of variable quality, and use inconsistent definitions of cycle regularity and ovulation.

    How It Works

    Myo-inositol is a precursor of inositol triphosphate, a second messenger in the insulin signalling cascade and in FSH signalling within the ovary. Many women with PCOS show a defect in converting myo-inositol to D-chiro-inositol in ovarian tissue, which impairs both pathways. Supplying myo-inositol supports insulin signal transduction, lowering circulating insulin.
    Lower insulin reduces ovarian androgen production and raises sex hormone binding globulin, which lowers free testosterone. That shift removes part of the block on follicular maturation, allowing more cycles to reach ovulation. Because the mechanism runs through insulin and follicular signalling, response is best in women with insulin resistance and weaker in lean PCOS phenotypes without metabolic features.

    Dosing & Protocol

    The standard regimen is 2 g of myo-inositol twice daily, giving 4 g per day, usually with 400 mcg folic acid. Many products use a 40:1 ratio of myo-inositol to D-chiro-inositol, mirroring the physiological plasma ratio. Cycle changes typically take three months, and most trials ran three to six months before assessing ovulation and cycle regularity.

    Rule out other causes first

    Irregular cycles can reflect thyroid disease, raised prolactin, low body weight or perimenopause. Get those excluded before assuming PCOS.

    Evidence

    The linked evidence comprises a 2018 BJOG meta-analysis of inositol for anovulation in PCOS, a 2007 Gynecological Endocrinology trial of myo-inositol alone and with clomiphene for ovulation induction, and a 2011 Human Psychopharmacology trial of myo-inositol in premenstrual dysphoric disorder. The meta-analysis reports improved ovulation rates but flags limited and inconsistent data on live birth and clinical pregnancy outcomes.

    Studies linked to this pairing.

    Myo-inositol in the treatment of premenstrual dysphoric disorder

    Score: 6/10
    2011
    rct

    Gianfranco C, Vittorio U, Maurizio N +3 more

    Myo-inositol reduced symptoms in women with premenstrual dysphoric disorder.

    View source

    Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients

    Score: 5/10
    2007

    Papaleo E, Unfer V, Baillargeon JP +7 more

    Myo-inositol alone and with clomiphene citrate restored ovulation in polycystic ovary syndrome patients.

    View source

    Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials

    Score: 8/10
    2018
    meta_analysis

    Pundir J, Psaroudakis D, Savnur P +5 more

    Inositol improved ovulation rate and cycle frequency versus placebo and produced metabolic improvements comparable to metformin.

    View source

    Safety

    Myo-inositol has a good tolerability record at 4 g per day. Mild nausea, gas and loose stools occur at higher intakes, typically above 12 g per day, and settle when the dose is reduced or split further. It is often chosen over metformin precisely because gastrointestinal side effects are less frequent, though metformin has far more long-term outcome data behind it.

    Fertility and pregnancy

    Restoring ovulation restores fertility, so contraception matters if pregnancy is not intended. Discuss use in pregnancy with your clinician; inositol is often continued but should be supervised.

    Interactions & Conflicts

    There are no established drug interactions of concern. The practical issues are additive: combined with metformin or other insulin-sensitising treatment it may lower glucose a little further, and combined with ovulation induction agents it changes the ovarian response, which is a matter for the prescribing specialist. High doses of D-chiro-inositol alone have been associated with poorer oocyte quality, so a myo-dominant 40:1 ratio is preferred.
    Interacts withSeverityMechanismAction
    moderate
    		——
    moderate
    		——
    moderate
    		——
    low
    		——
    moderate
    		——

    References

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.